Celecoxib‐Induced Erythema Multiforme with Glyburide Cross‐Reactivity
- 1 May 2002
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 22 (5) , 637-640
- https://doi.org/10.1592/phco.22.8.637.33200
Abstract
Erythema multiforme is an acute inflammatory skin reaction that often is caused by drugs, especially sulfonamides and their derivatives. Celecoxib, a cyclooxygenase‐2 inhibitor, is a sulfonamide derivative commonly prescribed to treat arthritis in patients who cannot tolerate or who have a contraindication for taking traditional nonsteroidal antiinflammatory agents. A 57‐year‐old man with a previously undocumented sulfa allergy experienced an allergic skin reaction and had difficulty breathing secondary to throat swelling. His condition was believed to be erythema multiforme associated with the introduction of celecoxib into his drug regimen. His drug therapy was discontinued, but a subsequent reaction occurred when the sulfonamide derivative glyburide was reintroduced. It is important for clinicians to obtain a careful history and perform a thorough medical evaluation in all patients receiving sulfonamides and their derivatives, as a potentially life‐threatening allergic reaction may be prevented.Keywords
This publication has 3 references indexed in Scilit:
- Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?Drug Safety, 2001
- Allergic Skin Reaction to CelecoxibDermatology, 2000
- Immunologic tolerability profile of celecoxibClinical Therapeutics, 1999